Vifor Pharma AG
F:G2AB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vifor Pharma AG
F:G2AB
|
CH |
|
C
|
Citigroup Inc
XMUN:TRVC
|
US |
|
D
|
DXC Technology Co
SWB:2XT
|
US |
|
A
|
Altria Group Inc
XMUN:PHM7
|
US |
|
Aena SME SA
F:A44
|
ES |
|
N
|
NioCorp Developments Ltd
F:BR3
|
US |
|
R
|
Roper Technologies Inc
XBER:ROP
|
US |
|
N
|
Nippon Yusen KK
XBER:NYKA
|
JP |
|
B
|
Bank of America Corp
XBER:NCB
|
US |
|
Thumzup Media Corp
NASDAQ:DTCX
|
US |
|
MI Technovation Bhd
OTC:MITNF
|
MY |
|
I
|
Intel Corp
SGO:INTC
|
US |
|
ASE Technology Holding Co Ltd
TWSE:3711
|
TW |
|
C
|
CS Disco Inc
NYSE:LAW
|
US |
|
A
|
AXA SA
SWB:AXAA
|
FR |
Bankruptcy Probability
Vifor Pharma AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vifor Pharma AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
V
|
Vifor Pharma AG
SIX:VIFN
|
10.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
618.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
317B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
239.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
250.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vifor Pharma AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vifor Pharma AG has total debt of 117m CHF. This includes both short-term (0 CHF) and long-term (117m CHF) debt.
You can find a full breakdown on its Balance Sheet.
